down arrow

Allergy Therapeutics Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00B02LCQ05
GBP
0.11
0.11 (53400.0%)

Dec 05

LON

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Animalcare Group Plc
SkinBioTherapeutics Plc
Provexis Plc
ProBiotix Health Plc
Allergy Therapeutics Plc
Futura Medical Plc
ImmuPharma Plc
Chill Brands Group Plc
Cel AI Plc
Gunsynd Plc
Apollon Formularies Plc
Why is Allergy Therapeutics Plc ?
1
Poor Management Efficiency with a low ROE of 1.26%
  • The company has been able to generate a Return on Equity (avg) of 1.26% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.18
  • Poor long term growth as Operating profit has grown by an annual rate -238.66% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.18
  • The company has been able to generate a Return on Equity (avg) of 1.26% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Operating profit has grown by an annual rate -238.66% of over the last 5 years
4
Flat results in Dec 24
  • OPERATING CASH FLOW(Y) Lowest at GBP -65.18 MM
  • RAW MATERIAL COST(Y) Grown by 5.22% (YoY)
5
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 101.92%, its profits have risen by 28.9%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Allergy Therapeutics Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Allergy Therapeutics Plc
-100.0%
-0.61
62.36%
FTSE 100
16.5%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-6.40%
EBIT Growth (5y)
-238.66%
EBIT to Interest (avg)
-8.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.41
Sales to Capital Employed (avg)
1.66
Tax Ratio
0.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.95%
ROCE (avg)
5.14%
ROE (avg)
1.26%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-56.33
EV to EBIT
-13.94
EV to EBITDA
-16.16
EV to Capital Employed
41.64
EV to Sales
7.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-298.77%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bullish
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Allergy Therapeutics Plc
Net Profit
Higher at GBP -8.56 MM
than preceding 12 month period ended Dec 2024
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (GBP MM)

Operating Profit
Highest at GBP -4.88 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (GBP MM)

EPS
Highest at GBP -0
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (GBP)

Cash and Eqv
Highest at GBP 21.68 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -319.48 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Allergy Therapeutics Plc
Operating Cash Flow
Lowest at GBP -65.18 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (GBP MM)

Raw Material Cost
Grown by 5.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."